GlassScriptPhysician profile
Natacha Telusca
NPI 1245557636
$2,363.09
in general payments reported to CMS, 2019-2025
7 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what 79% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2023: $355 · 2024: $132 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,575 · Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,575.00 |
| Food and Beverage | $663.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $1,575.00 | 2025 | Stimrouter Implantable Kit |
| Averitas Pharma INC. | $183.34 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $176.00 | 2025 | |
| Vertos Medical, INC. | $172.10 | 2023 | Mild Device Kit |
| Amgen INC. | $124.99 | 2019 | |
| Nalu Medical, INC. | $116.91 | 2024 | Nalu Neurostimulation System |
| Masimo Corporation | $14.75 | 2024 | Bridge, Patient Safetynet System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natacha Telusca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.